Evercore ISI maintains an "Outperform" rating for Walmart (NYSE:WMT), raising the price target to $111 from$110.Walmart partners with Abbott Laboratories to offer the Lingo continuous glucose monitor, expanding its healthcare offerings.The stock's current price of $107.05 reflects a slight decrease, but Evercore ISI's optimism suggests potential for growth.Walmart (NYSE:WMT) is a leading global retailer known for its vast network of stores and e-commerce platforms. It offers a wide range of products, from ...